Strengthening the UK clinical research environment

A recent ABPI report highlighted a decline in UK clinical trials. Improving the UK ecosystem for clinical research will involve a range of measures, and we look forward to publication of the O’Shaughnessy review. This sits alongside an ongoing substantial upgrade to UK clinical trials legislation and guidance, that forms the focus of this article.

The Windsor Framework – what does it mean for life sciences?

The Windsor Framework has been greeted with widespread enthusiasm so far, and indicates the start of a warmer relationship between the EU and the UK. We consider what it means for life sciences both in Northern Ireland and the wider UK.